株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の持続血糖測定モニタリング (CGM) 市場

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

発行 iData Research Inc. 商品コード 392595
出版日 ページ情報 英文 74 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.24円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の持続血糖測定モニタリング (CGM) 市場 US Market Report for Continuous Glucose Monitoring 2017 - MedCore
出版日: 2016年11月01日 ページ情報: 英文 74 Pages
概要

当レポートでは、米国の持続血糖測定モニタリング (CGM) 市場について調査分析し、市場の概要、市場分析と予測、促進要因・阻害要因、競合分析など、体系的な情報を提供しています。

第1章 調査手法

第2章 疾患の概要

  • イントロダクション
    • 糖尿病の種類
    • 糖尿病の合併症
    • 1型・2型糖尿病関連の危険因子
    • 兆候と症状
    • 糖尿病モニタリング
    • 治療
    • ドラッグデリバリーシステム

第3章 持続血糖測定モニタリング (CGM) 市場

  • イントロダクション
  • 市場の概要
  • 市場分析と予測
  • 促進要因・阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析

略語

目次
Product Code: iDATA_USDD17_MC_CGM

The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue over the forecast period and will be driven by favorable reimbursement, technological innovation and increased uptake of personal CGM among type 1 diabetics and insulin-dependent type 2 diabetics. Professional CGM is typically used in retrospective sessions initiated by physicians, during which a patient wears a CGM sensor for several days to a week, but is 'blinded' to the real-time CGM data and must adhere to frequent self-monitoring of blood glucose (SMBG) using traditional blood glucose meters. Additionally, the patient must maintain a record of their daily dietary intake and activity during the time that the sensor is worn. At the end of the session, the patient returns to their physician to remove the sensor and retrospectively analyze the glucose data that was collected. The 'blinded' aspect of professional CGM allows physicians to more easily assess their patient's behavior because their actions are not influenced by 'real-time' glucose data, as is the case with personal CGM products.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. INTRODUCTION
    • 2.1.1. Types of Diabetes
    • 2.1.2. Diabetes Complications
    • 2.1.3. Risk Factors Associated with Type 1 and Type 2 Diabetes
    • 2.1.4. Signs and Symptoms
    • 2.1.5. Diabetes Monitoring
    • 2.1.6. Treatment
    • 2.1.7. Drug Delivery Systems

CONTINUOUS GLUCOSE MONITORING MARKET

  • 3.1. INTRODUCTION
  • 3.2. MARKET OVERVIEW
  • 3.3. MARKET ANALYSIS AND FORECAST
    • 3.3.1. Total Personal Continuous Glucose Monitoring Market
      • 3.3.1.1. Personal Continuous Glucose Monitoring Receiver Market
      • 3.3.1.2. Personal Continuous Glucose Monitoring Transmitter Market
      • 3.3.1.3. Personal Continuous Glucose Monitoring Sensor Market
    • 3.3.2. Total Professional Continuous Glucose Monitoring Market
      • 3.3.2.1. Professional Continuous Glucose Monitoring System Market
      • 3.3.2.2. Professional Continuous Glucose Monitoring Transmitter Market
      • 3.3.2.3. Professional Continuous Glucose Monitoring Sensor Market
    • 3.3.3. Emerging Markets: Non-Invasive CGM
  • 3.4. DRIVERS AND LIMITERS
    • 3.4.1. Market Drivers
    • 3.4.2. Market Limiters
  • 3.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013-2023
  • Chart 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023
  • Chart 3-1: Continuous Glucose Monitoring Market by Segment, U.S., 2013-2023
  • Chart 3-2: Continuous Glucose Monitoring Market Breakdown, U.S., 2016
  • Chart 3-3: Continuous Glucose Monitoring Market Breakdown, U.S.,2023
  • Chart 3-4: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2013-2023
  • Chart 3-5: Total Personal Continuous Glucose Monitoring Market Breakdown, U.S., 2016
  • Chart 3-6: Total Personal Continuous Glucose Monitoring Market Breakdown, U.S.,2023
  • Chart 3-7: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2013-2023
  • Chart 3-8: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2013-2023
  • Chart 3-9: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2013-2023
  • Chart 3-10: Total Professional Continuous Glucose Monitoring Market by Segment, U.S., 2013-2023
  • Chart 3-11: Total Professional Continuous Glucose Monitoring Market Breakdown, U.S., 2016
  • Chart 3-12: Total Professional Continuous Glucose Monitoring Market Breakdown, U.S.,2023
  • Chart 3-13: Professional Continuous Glucose Monitoring System Market, U.S., 2013-2023
  • Chart 3-14: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2013-2023
  • Chart 3-15: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2013-2023
  • Chart 3-16: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2016

LIST OF FIGURES

  • Figure 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016(1 of 2)
  • Figure 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016(2 of 2)
  • Figure 1-3: Companies Researched in this Report, U.S., 2016
  • Figure 1-4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S.(1 of 2)
  • Figure 1-5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S.(2 of 2)
  • Figure 1-6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013-2016
  • Figure 1-7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016
  • Figure 1-8: Procedure Codes Investigated, U.S., 2016
  • Figure 1-9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016(1 of 2)
  • Figure 1-10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016(2 of 2)
  • Figure 1-11: Key Report Updates
  • Figure 1-12: Version History
  • Figure 2-1: Major Types of Diabetes and Related Pathologies, U.S., 2016
  • Figure 2-2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016
  • Figure 2-3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016
  • Figure 3-1: Continuous Glucose Monitoring Market by Segment, U.S., 2013-2023(US$M)
  • Figure 3-2: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2013-2023(US$M)
  • Figure 3-3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2013-2023
  • Figure 3-4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2013-2023
  • Figure 3-5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2013-2023
  • Figure 3-6: Total Professional Continuous Glucose Monitoring Market by Segment, U.S., 2013-2023(US$M)
  • Figure 3-7: Professional Continuous Glucose Monitoring System Market, U.S., 2013-2023
  • Figure 3-8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2013-2023
  • Figure 3-9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2013-2023
  • Figure 3-10: Drivers and Limiters, Continuous Glucose Monitoring Market, U.S., 2016
  • Figure 3-11: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2016
Back to Top